Tag | Content |
---|
EnhancerAtlas ID | HS178-10562 |
Organism | Homo sapiens |
Tissue/cell | Skeletal_muscle |
Coordinate | chr17:44255470-44257480 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
ESRRB | MA0141.3 | chr17:44255958-44255969 | TCAAGGTCATT | + | 6.32 | Esrra | MA0592.2 | chr17:44255957-44255968 | TTCAAGGTCAT | + | 6.62 | Esrrg | MA0643.1 | chr17:44255958-44255968 | TCAAGGTCAT | + | 6.02 | FOSL1 | MA0477.1 | chr17:44257162-44257173 | AGTGACTCATG | + | 6.14 | FOXF2 | MA0030.1 | chr17:44256130-44256144 | AATGTTTACCTTTA | - | 6.27 | POU2F2 | MA0507.1 | chr17:44256123-44256136 | ATATGCAAATGTT | - | 6.21 |
|
| Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
SE_09447 | chr17:44252954-44257809 | CD14 | SE_11745 | chr17:44252863-44257749 | CD20 | SE_13432 | chr17:44256276-44257429 | CD34_Primary_RO01536 | SE_17707 | chr17:44255439-44257522 | CD4p_CD25-_CD45RAp_Naive | SE_18395 | chr17:44255420-44257593 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19758 | chr17:44256123-44257319 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_54077 | chr17:44256258-44257596 | Spleen | SE_60799 | chr17:44255747-44273300 | DHL6 | SE_63056 | chr17:44256345-44273776 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 4 | Chromosome | Start | End |
chr17 | 44255490 | 44255540 | chr17 | 44255881 | 44256543 | chr17 | 44256587 | 44256667 | chr17 | 44256751 | 44257187 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I046178 | chr17 | 44255767 | 44258565 |
|
Enhancer Sequence | AGAGCAAAAC AATGATTCCT ATCCCACTTG ACCCCTACAA AATTCAAAAA GCTTCAATCT 60 TTGACAATGT AAAGCAGGGA AAGACTGTCA AATTTAAGCA GTTCTTAGAG AAGCTCAGGG 120 CTAAAGGAAA AAAAAACGAA AAACAAAAAA AGGAAGCAGT TCTACACAAA CAGCACAACA 180 GCCTATCTGA TAAATCATCT TTCTCCAAAG AATACAAAGC CTTAAAAGCT ATAATTAACT 240 GATTAATCCT CATAACAACC TGGGCAGTAG AATTAGGGCT GAGATTATAA TTTCTAATTT 300 ACCGGTGGGG ATAAAGTCAG ACTGTACATT CAGAATAAAA ATTCAAGCCC CAAATATCCC 360 AATTTTTAGT TCATTCAGTT AGTAAACTAT AATCTGACAA ATACAGATGG AGCTGCTACA 420 CCTGCTGTCA CTCACACAAA TTGAGATTCT GCAGTAAGCT TGTACAGATA AAAGAAAAGG 480 CTACCTATTC AAGGTCATTT AGCTATAAAA GGTTGGGCTA GATAATCAAT AGTTTCTCTC 540 TCAGTTTCAA AGAAGTATTT TAGGGTCTGG AAGATGTTAA ATGCACTCAG CAAGCAAATA 600 CATTTCGGAA AAACTTCCCA GATGGAGACT CACAACGTAT TGCATCATAC TGAATATGCA 660 AATGTTTACC TTTACCAAAC TTTTTTAACA AGCACCTTTT TCCATTACAT CTATTAATAT 720 CAAGCAGAAA CATCATTGTG AGAAATACAA GTTGGGATAA AGTTCAAATA TGTGACCTCT 780 AGGGTCCCTT CCTATGTTAA TTCTATTATT CTAAATTGCA CCATCGGTCC AAGGACAAAC 840 TTCTACCTAA CACAAGTGGC ACTTGGGAAG CAAAAATATA CTTCTAGGAT AGAGTTTCTC 900 AACCTAACCA CTAACTGACA TCTCACGATG AGTAATCTAT CACAGGGGGC TATCCTGGCA 960 GTAGCATGTT TAGCAACATC TCTGTTTTCC ACCCACTAGA TGCTAGTAGT GCCCTTCTGA 1020 AAATTATGAC AATCAAAAAT GTCTCCAGAC ATGTCAAATA TGGGAGCTGG GGGGTTCAAC 1080 ATCACACCTC CCAACAGAGA ACCATATCCT AAAGATTATA CACACACATA TATATACTCT 1140 TTCAAAAGCA AAACGTATCC AGCTGCTTCA AATACTGTAA GTCAGAACTA ACTCCACACC 1200 CACAAATGAA AACCTCATTT ATTCCCAGTC AATTTCCAAG ACAAGACTCC AGATACACAA 1260 GAATAACCTG GAAGCATCCA CCTTGCAAAA ATATTTAGCT GCAGAGAACA AAGGGGAAGG 1320 AATAGGTCAT CCAGGTGGCC AACAAGTATT ACAACCACAC TTGCACTGAA AGCAAAAGCA 1380 AAAATCAGAT GGGGAAGAAA AGTTTGCCCA TAATGTGGCT TCTACTAACC TCTTCCTTCA 1440 CCATTACCTC ATTTCTCTAC ACAAAGGACG GAAAGAAACA GCAGGAAGGA TGATTAGGGA 1500 AGTGTCCATG AAGTTGCCGC AATTTTAGCT GAGACTTGAA AATTAGCTAA AATGTCATTA 1560 TGCAAAAGGC TAGGACAAGA GAATGGTAAT GTGGCATTCT AGTGAGAGGA AATGGCATAA 1620 GAAAAGGCAA CGCTGTGTGG GAAAAGGCGA CATTCTGAAG GTTAAAAGAA ATGAACAATT 1680 TGGGCCGGGC GCAGTGACTC ATGCCTATAA TCCCAGGACT TTGGGAGGCT GAGGCGGGTA 1740 GATCACCTGA GATCAGGAGA CCAGCCTGGC CAACATGGCG AAACCCCATC TCTACTAAAA 1800 TTACCAAAAA TTAGCCGGGT GTGGAGGCGC GCACCTGTAC TCCCAGCTAC TTGGAAGACT 1860 GAGACAGGAT AATTGCTTGA ACCCAGGAGG CAGAGGTTGC AGTGAGCTGA GATCGGGCCA 1920 CTGCACTCCA GCTTGGGTAA CAAGAGCGAG ACTCCATCTT AAAAAAAAAA AAAAATTAAC 1980 AATTTGCTTA AAACACAAAG CATATTTTAA 2010
|